News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
High-quality, repeatable imaging is the cornerstone of managing diabetic eye disease
In the article “Managing diabetic eye disease eased with repeatable, high-quality imaging” recently published in Modern Retina, Dr. David Eichenbaum highlights various SPECTRALIS multimodal imaging platform features and their benefits in managing diabetic eye disease. He delves into the importance of having dependable and consistent imaging capability within the retina practice.
Read more
Reflections on durable therapies for diabetic macular edema amid COVID-19 pandemic
An article in Ophthalmology Times by Dr. Caesar Luo overviews considerations for sustainable DME management options during the everchanging COVID-19 healthcare landscape, with an emphasis on the backlog caused by patients’ reluctance to visit clinics during the pandemic. It includes an interesting case study imaged using a SPECTRALIS OCT.
Read more
NOTICE: LOG4SHELL GAP
The Log4Shell gap is a global security risk that affects a commonly used Java logging library (Log4j). We are pleased to inform you that no Heidelberg Engineering product is affected by the Log4j vulnerability, this includes products designed and manufactured by our subsidiaries, MedicalCommunications and Medisoft.
Read more
VIDEO: Presenter reviews retinal vascular disease treatment pipeline (ARVO)
Jessica Steen, OD, FAAO, and Associate Professor at Nova Southeastern College of Optometry overviews her SECO presentation on “Evolving Trends in Retinal Vascular Disease,” which highlights the importance of the optometrist in the early detection, referral, and long-term co-management of patients.
Read more
Uncover our contributions to ophthalmic science interactively
A snapshot of Heidelberg Engineering Association for Research in Vision and Ophthalmology (ARVO) 2021 activities and scientific programming presence at the annual meeting, held virtually.
Read more
Earlier Detection of Glaucoma Progression Using High-Density 3D SD-OCT
A recently published peer-reviewed study followed 124 patients with open-angle glaucoma over a 5-year period. Subjects were scanned annually using SPECTRALIS SD-OCT to complete RNFL thickness scans, and optic nerve volume scans. Results exhibited that glaucoma progression can be detected approximately one to two years earlier in comparison to other currently available imaging.
Read more
Publication alert: “MultiColor and autofluorescence imaging - What’s in a name?”
Adapted from Dr. Giovanni Staurenghi’s presentation at the American Academy of Ophthalmology 2020 all virtual meeting, this article by Ophthalmology Times highlights the significant benefits found in both MultiColor and near infrared imaging with SPECTRALIS, including better visualization of certain pathologies.
Read more
Dr. Rahul Pandit Discusses the Value of HRT3 RCM
Dr. Pandit shared his perspective on the clinical value of HRT3 RCM with Healio OSN during ASCRS 2021
Read more
SPECTRALIS High Magnification Module Features in OPS
A recent issue of Journal of Ophthalmic Photographers featured an assessment of photoreceptor cells using SPECTRALIS’ High Magnification Module (HMM).
Read more
Xtreme Research Award winners explain “OCT Neuro-Toolbox” examinations
The winners of the Xtreme Research Award 2021 have brought neuro-ophthalmology to the forefront of ocular imaging and innovation with their “OCT Neuro-Toolbox” approach.
Read more